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Protein secretion in Gram-negative bacteria {#s01}
===========================================

All cells are surrounded by an envelope whose prime function is to delineate the contour of the cell unit \[[@bib-001]\]. This envelope prevents the cellular content from leakage and protects it from disruption by damaging agents. However, cells cannot survive without establishing an active communication with the external environment. For example, waste generated by the cell metabolism needs to be released and nutrients essential for growth need to be taken up. Consequently, many molecular machines are in place within the cell envelope, which provide multiple paths for exchange of ions, small molecules or macromolecules, such as proteins. Bacteria are single-cell organisms and are classified as Gram-negative or Gram-positive depending on the structure of their cell envelope \[[@bib-001],[@bib-002]\]. Both have a cytoplasmic membrane, but Gram-negative bacteria have an additional asymmetrical bilayer called the outer membrane. In this case, proteins targeted to the outside (exoproteins) have to pass two successive membrane hurdles. Over the course of evolution, these bacteria have developed sophisticated nanomachines, which are macromolecular complexes spanning both membranes and which guide the exoproteins from the inside to the outside \[[@bib-003],[@bib-004]\]. These exoproteins can be toxins targeted to host cells in the case of bacterial pathogens but also enzymes whose role is to digest non-utilisable complex food sources into basics nutrients that can then be readily taken up into the cell.

Why so many different secretion systems? {#s02}
========================================

To date, six different protein secretion systems have been characterized in detail \[[@bib-005]\]. The real difference between these systems is simply in the components that form the transport machinery. In some cases, one protein inserted into the outer membrane will be sufficient to give access to the external medium, while the rest of the information needed for targeting is contained in the exoprotein. This is the case for the T5SS whose archetype is the IgA protease from *Neisseria meningitidis* \[[@bib-006]\]. In contrast, others, such as the T3SS, have hugely complex structures composed of not less than 15-20 proteins, which assemble into a gigantic puzzle whose shape and localisation within the cell envelope is visible using cryo-electron microscopy (cryo-EM) \[[@bib-007],[@bib-008]\], as first visualized with *Salmonella typhimurium* \[[@bib-009]\]. These complex secretion machines span both cytoplasmic and outer membranes and can be powered using ATP as fuel to expel proteins to the outside. Importantly, a single organism will not necessarily use only one type of secretion system. For example, *Pseudomonas aeruginosa* has them all \[[@bib-010]\] except for the T4SS, which was discovered in *Agrobacterium tumefaciens* \[[@bib-011],[@bib-012]\].

The fundamental question is why does an organism put so many different systems in place to perform the same job? The answer might be two-fold; firstly, they might do different jobs and secondly, the organism did not plan which system to adopt in advance. Some secretion systems, such as the T1SS and T2SS, essentially release enzymes, such as proteases or lipases, into the surroundings and these enzymes can then chew up food for further assimilation by the cell. Note that in pathogens, these enzymes can cause severe damage to the tissues. Moreover, the exotoxin A of *P. aeruginosa* \[[@bib-013]\] is released in a T2SS-dependent manner and then taken up by retrograde transport into host target cells where it disrupts cellular functions \[[@bib-014]\]. In the case of the T3SS and T4SS, the delivery of toxins to target cells is more direct since it involves cell-to-cell contact via a specific structure of the secretion system that emerges at the surface of the bacterial cell. In the case of the T4SS, this emerging part resembles a conjugative pilus, which is used to exchange DNA between bacteria during the conjugation/mating process \[[@bib-015]\]. One may imagine that bacteria have evolved a system initially used to exchange DNA into a system that is used to inject toxins into eukaryotic cells. Another example of this evolution paradigm is the transformation of an apparatus used to assemble a flagellum at the cell surface (an appendage involved in bacterial motility) into an apparatus that assembles a needle-like structure better suited to contact and inject toxins into target cells \[[@bib-016]\]. Along these lines, the T2SS has adapted the contractile capability of Type IV pili to design a shorter piston-like structure, or pseudopilus, involved in propelling the T2SS substrate outside the cell \[[@bib-017],[@bib-018]\].

The Type VI secretion system resembles the bacteriophage structure {#s03}
==================================================================

Slight modification of already existing macromolecular complexes and the adaptation of their initial function to achieve a new goal is a common feature in the development of secretion systems. In all cases, the idea is to use an existing machine, providing access to the external medium, providing cell contact capacity or transferring macromolecules, such as DNA, thus turning it into a proper protein delivery system. The T6SS is the most recently discovered secretion type \[[@bib-019]\]. The initial observation described clusters of about 15 conserved genes of which two were encoding components similar to those found in the T4SS (IcmF and DotU). Because of this, the suspicion emerged that this cluster could be encoding a new secretion machine. However, the exact nature of the remaining components was unknown due to lack of similarity with proteins already in the databases. When the common ancestor is very ancient, the amino acid sequence similarity between evolved proteins is hardly identifiable. However, what is frequently conserved is the overall structure and fold. This is where the breakthrough came from, since two T6SS components (namely VgrG and Hcp) were finally recognized as homologous to the gp27/gp5 and gp19 bacteriophage proteins \[[@bib-020]-[@bib-022]\] ([Figure 1](#fig-001){ref-type="fig"}).

![The Type VI secretion system\
**(A)** The H1-type V1 secretion system (H1-T6SS) cluster from *Pseudomonas aeruginosa*. The nomenclature is as published previously \[[@bib-019]\]. The colour code used for the genes corresponds to the encoded proteins as shown in panel B.\
**(B)** Protein secretion via the type V1 secretion system (T6SS) is compared with the bacteriophage DNA injection mechanism. On the left, a bacteriophage has landed on the surface of a bacterium. The DNA in the capsid is injected via the tail into the cytoplasm (C) of the bacterium. Highlighted is the tail tube (yellow), which is made with gp19, the tail sheath (blue) made with gp18 subunits and the puncturing device (red) made with gp27 and gp5. Next to the phage, the T6SS is represented and basically is an inverted phage tail. The colour code corresponds to the genes indicated in panel A and highlights the similarities with the phage. The HsiB/HsiC complex is the *Pseudomonas aeruginosa* T6SS sheath structure (also known as VipA/VipB or TssB/TssC) (see also [Figure 2](#fig-002){ref-type="fig"}). TheT6SS tube is composed of Hcp (yellow) and the puncturing device is known as VgrG (red). The green and pink components are a representation of the IcmF/DotU/Lip complex, which connects the inner membrane (IM) and outer membrane (OM) through the peptidoglycan layer (PG). Upon contact with another bacterial cell (as shown on the right), the sheath contracts and pushes the puncturing device and tube through the cell envelope and punches the target bacterial cell. In the case of the *P. aeruginosa* H1-T6SS, three toxins are then injected (Tse1-3). Once the contraction has taken place, the sheath is disassembled by the AAA ATPase ClpV (purple) and the system is reset for a new round of toxin injection. For more details see main text.](biolrep-05-52-g001){#fig-001}

The gp proteins are central components of the bacteriophage\'s tail, such as in the T4 phage \[[@bib-023]\] ([Figure 1](#fig-001){ref-type="fig"}). Bacteriophages are bacterial viruses that inject their DNA into target bacterial cells. These bacteria are used as cell factories to replicate the phage DNA and to encode the structural components of the bacteriophage. The new virus particles are released by bursting the host bacterium and are then ready to infect new target cells. In brief, gp19 is the basic unit of the tail phage tube and displays structural homology with Hcp ([Figure 1](#fig-001){ref-type="fig"}). The three-dimensional (3D) structure of the Hcp protein from *P. aeruginosa* was solved in 2006 \[[@bib-020]\], and Hcp forms a hexameric structure with a central channel of 40 Å. These hexamers can pile up on top of each other forming nanotubes resembling the gp19 tail phage tube \[[@bib-024],[@bib-025]\]. The gp27 and gp5 proteins form a heterotrimeric complex (gp27~3~/gp5~3~) in which gp5 is made of a series of small beta strands which, once assembled into a trimer, form a sharp and rigid needle structure \[[@bib-026]\]. This needle is placed on the trimeric gp27 complex, which is sitting on top of the gp19 tail tube. Interestingly, the VgrG protein is made of two domains; the N-terminal domain resembling gp27, while the C-terminus has a gp5-like structure \[[@bib-021],[@bib-027]\].

The function of the phage gp27/gp5 puncturing device is to create a hole in the outer membrane of the target cell and to allow injection of the phage DNA through the gp19 tube ([Figure 1](#fig-001){ref-type="fig"}). This puncturing event also involves a tail sheath that surrounds the gp19 tube. This sheath structure is composed of more than a hundred copies of a protein called gp18, is contractile, and upon contraction pushes the tail tube and the puncturing device through the outer membrane and into the bacterial cell \[[@bib-028]\]. Electron microscopy studies have shown that two proteins of the T6SS, generically named VipA/VipB or TssB/TssC, form tubular structures, resembling cogwheels when viewed from the top \[[@bib-029],[@bib-030]\] ([Figure 2](#fig-002){ref-type="fig"}) and this structure cycles between extended and contracted conformations, further highlighting the conserved contractile mechanism \[[@bib-031],[@bib-032]\]. These two proteins assemble to form a complex analogous to the gp18 structure \[[@bib-033]\].

![The tail sheath-like structure of the T6SS\
Model for the *Pseudomonas aeruginosa* HsiB/HsiC type V1 secretion system (T6SS) tail sheath as seen from the side **(A)** or from the top **(B)**. The model is based on electron microscopy images as shown in **(C)** and also described elsewhere \[[@bib-030]\]. In panel C the scale shown at the top left corner is 90 nm.](biolrep-05-52-g002){#fig-002}

The set of conserved T6SS components not only include TssB and TssC but also TssA, TssEFG and TssK. It is not yet known what the role of these proteins is in the T6SS, but since the homology between the phage tail and the T6SS is becoming obvious, the trail should lead us towards a more direct comparison with gp proteins that form the baseplate of the phage \[[@bib-034]\]. The baseplate is a complex that is central to the phage tail structure \[[@bib-035]\]. It contains proteins, such as gp48/gp54, which are essential to initiate elongation of the gp19 tail tube. Other proteins, such as gp6/gp25/gp53, form part of a wedge surrounding the puncturing device gp27/gp5. Finally, a subset of gp proteins act as adapters and short tail fibers, such as gp9 and gp12. The similarity between gp25 and TssE has now been demonstrated \[[@bib-036]\] and this trail is likely to take us towards the identification of further structural similarities between other T6SS components and some of the gp proteins named above. One should note here that it is unlikely that IcmF (TssM) and DotU (TssL) or the Lip (TssJ) components of the T6SS share any similarity with phage components. Instead, it has been shown that they are membrane bound, that they interact tightly with each other and are likely to form the docking area for the T6SS within the membrane, thus substituting for the docking role of the phage tail fibers \[[@bib-037],[@bib-038]\].

In light of the previous observations, it is likely that the T6SS is a phage tail-like structure, with the major difference being that the phage punctures the cell from the outside to inject DNA, whereas the T6SS punctures the cell from the inside to secrete proteins ([Figure 1](#fig-001){ref-type="fig"}).

The Type VI secretion system delivers bacterial toxins {#s04}
======================================================

The phrase "Tell me who you haunt and I will tell you who you are" comes from "Don Quixote" by Miguel de Cervantes and is now a French proverb. This quote introduces the concept that the function of a secretion system is primarily deduced from the type of proteins/effectors transported by the system. As mentioned previously, the T2SS from *P. aeruginosa* can have multiple functions, such as food acquisition *via* the secretion of lipases/proteases and cytotoxicity by the release of the ADP-ribosylating exotoxin A.

In the case of the T6SS, very few effectors were characterized until recently. The first effector to be identified was a VgrG protein from *Vibrio cholerae* (VgrG-1), which has a C-terminal extension in addition to the gp27/gp5 domain \[[@bib-021]\]. This C-terminal extension is an actin cross-linking domain (ACD) \[[@bib-039]\]. The ACD of VgrG-1, once injected into macrophages or amoeba, impairs the phagocytic activity of the cell by acting on the cytoskeleton and may cause cell death \[[@bib-040]\]. Another example where the secreted protein is a C-terminal extension of a VgrG protein is the VgrG1 from *Aeromonas hydrophila* \[[@bib-041]\]. In this case, the C-terminal extension is a VIP-2 domain with ADP ribosyltransferase activity. Injection of this domain into HeLa cells causes actin cytoskeleton disruption and apoptosis. Through these two examples, it has been suggested that the T6SS is a bacterial pathogen device whose primary function (as with the T3SS or T4SS) is to subvert signalling in eukaryotic cells and to take advantage of this process and survive in the infected host.

The reality is clearly different. In 2010, Hood and collaborators made the striking observation that one of the three T6SSs in *P. aeruginosa* delivers three toxins into other bacteria \[[@bib-042]\] ([Figure 1](#fig-001){ref-type="fig"}). Two of these toxins, namely Tse1 and Tse3, are injected into the periplasm of Gram-negative bacteria \[[@bib-043]\]. There, they degrade the peptidoglycan, which provides shape and rigidity to the bacterial cell. As a result, the target bacterium rounds up and eventually bursts. Tse2\'s function is unknown but it is likely that it is injected into the cytosol, inhibiting further cell growth \[[@bib-042]\]. Each of the genes encoding the Tse toxins is organized in tandem with another gene coding for a specific immunity protein which, when expressed, protects the cells from the activity of the toxin. Since then, a whole family of T6SS-associated toxin/immunity couples have been reported \[[@bib-044]\], for example, in *V. cholerae, Burkholderia* species or *Serratia marcescens* \[[@bib-045]-[@bib-047]\].

This is a very exciting and important observation, which completely turned around the vision one had of the role of T6SS. The hypothesis now is that the T6SS is a key weapon not exclusively to attack a host but to compete with other bacteria living in the same host or environmental niche. Thus, it is proposed that the T6SS shapes the composition of a microbial population in one particular niche or within a mixed-species biofilm. It may also still be an important host colonization factor in the case of polymicrobial infections, such as in the lungs of cystic fibrosis patients.

Different bacteria use the T6SS in different ways. For example, *P. aeruginosa* uses the T6SS weapon against bacteria that show aggressive behaviour. The recent study by Basler and collaborators showed that when *V. cholerae* is mixed with *P. aeruginosa*, both bacteria produce active T6SS which results in the rounding up and lytic death of the *Vibrio* cells \[[@bib-048]\]. Interestingly, when the *V. cholerae* cells included in the mix are T6SS-defective, no *P. aeruginosa-*dependent T6SS killing is observed. This demonstrates that *P. aeruginosa* uses its T6SS in a tit-for-tat strategy and in this case, responds to any T6SS-dependent attack of *Vibrio* cells.

Is the puncturing device a multifunctional delivery system? {#s05}
===========================================================

It is now clear that effectors from the T6SS can come at least in two flavours. One set of effectors is a C-terminal extension of the VgrG puncturing device and is mostly targeted to eukaryotic cells. The second set is made of "free" toxins involved in bacterial competition and killing. However, recent developments suggest that it might not be such a clear-cut case. Indeed, VgrG-3 from *V. cholerae* has a C-terminal extension, whose function is also to target the bacterial peptidoglycan \[[@bib-049],[@bib-050]\]. Immediately downstream of the gene encoding VgrG-3, one can find a gene that encodes the cognate immunity protein, TsaB \[[@bib-049]\].

The question behind this observation is how are the "free" toxins secreted? One obvious suggestion is that although they are not covalently linked to a VgrG protein, they might potentially interact with the C-terminus of one such protein. A large number of VgrG proteins do not have any C-terminal extension and are termed canonical VgrG, as opposed to evolved VgrG (which have a C-terminal extension). It is thus a possibility that these canonical VgrGs may interact with "free" toxins via their C-terminus and will carry the effector into target cells as occurs with evolved VgrGs. In this case, it is possible that the VgrGs effectively have a dual function that is puncturing the cell envelope and transporting the effectors. Furthermore, it has also been proposed that proteins, such as members of the PAAR family, could bind to the tip of the VgrG proteins and be used as adaptors for additional T6SS toxins \[[@bib-051],[@bib-052]\].

What are the next challenges? {#s06}
=============================

Remarkably, 3D reconstruction based on cryo-EM images have provided a great deal of information about the assembly and structure of the bacteriophage tails. By contrast, structural data on the T6SS are rather scarce, and most of the knowledge is inferred from comparison with the phage. There are only a few images available, for example, the T6SS tail sheath-like structure \[[@bib-030],[@bib-053]\] and the *in situ* cryo-EM images of a long tubule extending into the cytoplasm \[[@bib-054]\]. However, there is still a long way to go in following the bacteriophage trail and providing further structural comparisons.

This idea of the tail sheath contracting and pushing the puncturing device into target cells is appealing, but needs further demonstration. Importantly, there have been several reports describing that in the T6SS, an AAA ATPase (i.e. ClpV) is involved in recycling the tail-sheath components VipA/VipB after sheath contraction \[[@bib-032]\]. Sheath disassembly might then allow for a new round of assembly/contraction and injection of toxins into target cells. In the absence of ClpV, it is proposed that T6SS contraction happens only once and thus only one delivery of toxins occurs, resulting in poor T6SS activity \[[@bib-055]\]. Understanding the dynamic of the T6SS is an important challenge. Reports presenting live images of bacterial cells expressing GFP- or mCherry-tagged T6SS components are flourishing and could be the development needed to address this question \[[@bib-031],[@bib-056],[@bib-057]\]. In these images, bacteria can be seen battling against each other through flashes of fluorescence.

A great deal is to be expected from the discovery of new effectors and the greater the variety, the greater the functional potential of the T6SS. In the case of *P. Aeruginosa*, the genes encoding these effectors are not necessarily clustered with the T6SS genes, making their identification more complex. Recently, it has been suggested that a superfamily of phospholipases is a T6SS effector. The genes encoding these Type VI lipase effectors (*tle*) are not adjacent to complete T6SS gene clusters but adjacent to genes encoding orphan VgrG proteins \[[@bib-058]\]. Again, how the T6SS effectors are transported is still unclear, and whether the effectors are transported through the T6SS tube or are bound to VgrGs forming the T6SS tip awaits further demonstration.

Finally, it seems that the T6SS may play a role against both eukaryotic and prokaryotic cells. The role played by bacterial competition in pathogenesis and its importance (if any) is yet to be understood.

In conclusion, the T6SS has attracted the immediate attention of a number of microbiologists. Its unique structure and relationship with a bacterial virus will foster understanding of evolution mechanisms. Its increasingly relevant role in bacterial competition and its ability to control bacterial population makes it highly relevant to ecology, agriculture and medicine. Finally, the structural complexity and functional diversity of the T6SS is a vast playground for cutting edge research and understanding of basic principles in biology.
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